Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 12, 2007

Cleveland BioLabs to Build Facility at Roswell Park to Aid Product R&D

  • Cleveland BioLabs is partnering with Roswell Park Cancer Institute to develop the company's cancer and radio-protectant drug candidates.

    Under the strategic research partnership, Cleveland BioLabs will establish a research and clinical facility at the Roswell Park campus in Buffalo, NY, which will become the foundation for its advanced research and clinical trials.

    Roswell Park and various agencies of the state of New York will provide Cleveland BioLabs with up to $5 million of nondilutive funding. The company will have an open-ended license to any basic research conducted within or in collaboration with its Roswell Park laboratory.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »